Crossmark

Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioning

Crossref DOI link: https://doi.org/10.1007/s00277-022-05017-0

Published Online: 2022-11-10

Published Print: 2023-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Wenqiu

Xue, Song

Zhang, Yongping

Liu, Fuhong

Tian, Min

Wang, Yanping

Li, Fang

Lu, Yiyan

Wang, Jingbo
License Information

Text and Data Mining valid from 2022-11-10

Version of Record valid from 2022-11-10
More Information

Article History

Received: 26 January 2022

Accepted: 22 October 2022

First Online: 10 November 2022

Declarations

:

: This is a retrospective case note review for which ethical approval was not required.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below